Neuro-Nanomedicine

Blood-brain barrier protects the central nervous system from conventional therapeutics. This feed focuses on the development and use of nanomedicine for neurological diseases.

September 26, 2020
Open Access

Pickering Emulsion-Based Microreactors for Size-Selective Interfacial Enzymatic Catalysis

Frontiers in Bioengineering and Biotechnology
Jieqing LeiZhigang Luo
September 24, 2020

Nanofactories for Controlled Synthesis and Delivery of Nucleoside Analogue Therapeutics

Chembiochem : a European Journal of Chemical Biology
Kourosh H Ebrahimi
September 25, 2020

Structural Variants of poly(alkylcyanoacrylate) Nanoparticles Differentially Affect LC3 and Autophagic Cargo Degradation

Journal of Biomedical Nanotechnology
Tonje SønstevoldMaria Lyngaas Torgersen
September 24, 2020

Nanoscale Drug Delivery Systems for Glaucoma: Experimental and In Silico Advances

Current Topics in Medicinal Chemistry
Smriti Sharma, Vinayak Bhatia
September 25, 2020

Development of red-light cleavable PEG-PLA nanoparticles as delivery systems for cancer therapy

Colloids and Surfaces. B, Biointerfaces
Camila G DarivaArménio C Serra
September 25, 2020
Review

A systematic review of the biodistribution of biomimetic high-density lipoproteins in mice

Journal of Controlled Release : Official Journal of the Controlled Release Society
Dennis Pedersbæk, Jens B Simonsen
September 24, 2020

Nanomedicine and early cancer diagnosis: molecular imaging using fluorescence nanoparticles

Current Topics in Medicinal Chemistry
Ke-Tao JinYun-Fang Chen
September 26, 2020
Review

The Efficacy of Cholesterol-Based Carriers in Drug Delivery

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Ngonidzashe Ruwizhi, Blessing Atim Aderibigbe
September 26, 2020

Preparation, Evaluation and In vitro Cytotoxicity Studies of Artesunate-loaded Glycyrrhetinic Acid Decorated PEG-PLGA Nanoparticles

Drug Development and Industrial Pharmacy
Xuwang PanJinsong Huang
September 25, 2020
Open Access

Computational Analysis of Clinical and Molecular Markers and New Theranostic Possibilities in Primary Open-Angle Glaucoma

Journal of Clinical Medicine
María D Pinazo-DuránJavier Moreno-Montañés
September 26, 2020
Review
Open Access

Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance

Frontiers in Molecular Biosciences
Yihan YaoAnwen Shao
September 24, 2020

Hyaluronan based Multifunctional Nano-carriers for Combination Cancer Therapy

Current Topics in Medicinal Chemistry
Menghan GaoWeiqi Zhang
September 26, 2020

The Smart Dual-Stimuli Responsive Nanoparticles for Controlled AntiTumor Drug Release and Cancer Therapy

Anti-cancer Agents in Medicinal Chemistry
Feng WuYong Diao

Sign up to follow this feed and discover related papers.

Related Feeds

Adult Kidney Organoids at Single Cell Resolution

Single-cell RNA sequencing of the adult human kidney transcriptome can provide molecular information about cell-specific responses to environmental variables and disease states. This information can provide a dataset to benchmark human kidney organoids. Discover the latest research on adult kidney organoids at single cell resolution here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

© 2020 Meta ULC. All rights reserved
/feed-previews/neuro-nanomedicine/b74e8972-a30d-445f-83d8-8937fe875297